Accelr8 Posts 50-Percent Decline in Fiscal 2006 Revenue as Net Loss Doubles | GenomeWeb
NEW YORK (GenomeWeb News) — Accelr8 Technology today said that total year-end revenue fell by more than half as net losses increased by roughly half.
 
Revenue for the 12 months ended July 31 slid to $212,000 from $500,000 in 2005, and the company lost $3 million on the year, about 50 percent more than last year.
 
The company said in 2006 it completed its transition to an R&D operation, with its resources directed towards its BACcelr8r platform, particularly towards its BACcel-1.0.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.